Social Media Sidebar

Announcement

Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

We are all now connected by the Internet, like neurons in a giant brain.

 

Stephen Hawking

 

'Living Drug' That Harnesses Immune System Clears Hurdle

RATE THIS! +38
Posted in Medicine on 15th Jul, 2017 04:16 PM by Alex Muller
A Food and Drug Administration advisory committee unanimously recommended that the agency approve a "living drug" approach for children and young adults who are fighting a common form of leukemia. The agency doesn't have to follow the committee's recommendation but usually does.
 
The treatment takes cells from a patient's body, modifies the genes, and then reinfuses those modified cells back into the person who has cancer. If the agency approves, it would mark the first time the FDA has approved anything considered to be a "gene therapy product."
 
The treatment is part of one of the most important developments in cancer research in decades, finding ways to harness the body's own immune system to fight cancer. And while it has generated much hope, there are some concerns about its safety over the long term, and its cost.
 
Even so, several of the committee members were unusually enthusiastic in explaining their 10-0 vote recommending approval.
 
"This is the most exciting thing I've seen in my lifetime," said Dr. Timothy Cripe, an oncologist at the Nationwide Children's Hospital in Columbus, Ohio.
 
"This is a major advance and is ushering in a new era in treating children," agreed Dr. Malcolm Smith, associate branch chief for pediatric oncology at the National Cancer Institute.
 
For years, scientists have tried to use drugs that stimulate the immune system to fight cancer, and have had only modest success.
 
In recent years, however, scientists developed a new generation of "immunotherapy" drugs that have produced impressive results for a wide range of cancers by unleashing the body's natural defense system.
 
The new treatment is known as CAR-T cell immunotherapy. It works by removing key immune system cells known as T cells from the patient so scientists can genetically modify them to seek out and attack only cancer cells. That's why some scientists refer to this as a "living drug."
 
Doctors then infuse millions of the genetically modified T cells back into the patient's body so they can try to obliterate the cancer cells and hopefully leave healthy tissue unscathed.
 
"It's truly a paradigm shift," said Dr. David Lebwohl, who heads the CAR-T Franchise Global Program at the drug company Novartis, which is seeking the FDA's approval for the treatment. "It represents a new hope for patients."
 
The drug endorsed by the advisory panel is known as CTL019 or tisagenlecleucel. It was developed to treat children and young adults ages 3 to 25 who have relapsed after undergoing standard treatment for B cell acute lymphoblastic leukemia, which is the most common childhood cancer in the United States.
 
While this blood cell cancer can be highly curable, some patients fail to respond to standard treatments; and a significant proportion of patients experience relapses that don't respond to follow-up therapies.
 
"There is a major unmet medical need for treatment options" for these patients, Dr. Stephen Hunger, who helped study at the Children's Hospital of Philadelphia, told the committee.

Tags: cancerhealthmedicineoncologydrug

Read original article » Back to category

Comments

View comments by:


 

Recent headlines

  • Posted in Science on 2017-07-27 15:19:10
    Could 'cocktail geoengineering' save the climate?..read more
    Posted in Science on 2017-07-27 15:13:16
    Ketamine has 'truly remarkable' effect on depression..read more
    Posted in Science on 2017-07-27 14:59:50
    Renewable Energy Just Hit a Big Milestone..read more
    Posted in Medicine on 2017-07-26 17:05:11
    Eye test could help diagnose autism..read more
    Posted in Science on 2017-07-26 16:55:24
    Cognitive cross-training enhances learning, study finds..read more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in about.....read more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for commercial.....read more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 Downloads..read more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into new.....read more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs,.....read more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for commercial.....read more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short Sighted..read more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, but.....read more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in about.....read more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target mitochondria..read more

Recent Blog Posts

  • Posted by AlexMuller
    Nanoparticle vaccine shows potential as immunotherapy to fight.....read more
    Posted by AlexMuller
    Obesity is top cause of preventable life-years lost, study shows..read more
    Posted by AlexMuller
    Light can be utilized to control gene function..read more
    Posted by AlexMuller
    Brain stimulation restores memory during lapses, research shows..read more
    Posted by AlexMuller
    Wax worm caterpillar will eat plastic shopping bags: New.....read more

Login to your Account

Login to your PlanetTech Account here

Username:
Password:
Remember me
or

Create a New Account

You just need username and password

The following errors occured:
Username:
Email:
Password:
Verify password:
Remember me